Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Du bruger tilsyneladende en bredere skærm. Vil du gerne give denne side en bredere visningsoplevelse?

Audientes – Presentation of Q2/H1 2024 report

Af Michael FriisHead of Equities
Audientes

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

Audientes expects to release its H1 results on 29 August 2024. Audientes’ CEO Steen Thygesen will present the results, provide a business update, and answer questions at a virtual live event on 30 August at 13.00.

In the Q1 2024 results, Audientes realized around DKK 0.2m in revenue, but lowered the loss to DKK 2.6m (DKK 3.8m in Q1 2023). In the second quarter, Audientes made a rights issue that was subscribed to 94 percent, corresponding to approximately DKK 4.59 million in new capital and conversion of debt. Furthermore, they have announced new distribution partners in India, the Middle East, and Africa. After the period, they also signed a definitive agreement for a joint venture on the Chinese market. The expectations for those agreements and the capital situation will be in focus besides the financial results.

Audientes A/S is a Danish hearing health company specializing in smart, self-fitting affordable hearing aids and advanced hearables. Audientes’ unique hearing aid solution, Ven™ by Audientes, is available for purchase in the Indian and Nepalese markets and is expected to be introduced in other markets in the coming years.

Disclaimer: HC Andersen Capital receives payment from Audientes for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 13.34, 19 August 2024.

Seneste videoer

Investor Day | Nov. 24, 2025
23.12.2025, 11.00 United Bankers
HCA Morgenbørs 23/12 - Flade futures og fokus på Novo Nordisk og Ørsted
23.12.2025, 09.27 Novo Nordisk
HCA Morgenbørs 22/12 - Positiv stemning i Asien og amerikanske futures i plus, mens Europa er fladt
22.12.2025, 09.28 GomSpace Group
HCA Morgenbørs 19/12 - Små fald i den europæiske åbning og fokus på flere danske aktier
19.12.2025, 09.25 Aquaporin
Talenom - Planned demerger and strategies of Talenom and Easor
18.12.2025, 11.00 Talenom
Vis alle videoer
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.